Sigma-Aldrich Corporation To Present At 32nd Annual J.P. Morgan Healthcare
ST. LOUIS, Dec. 19, 2013
ST. LOUIS, Dec. 19, 2013 /PRNewswire/ --Sigma-Aldrich Corporation (NASDAQ:
SIAL), a leading Life Science and High Technology company, announced that
Rakesh Sachdev, President and Chief Executive Officer, will be presenting at
the 32^nd Annual J.P. Morgan Healthcare Conference on Monday, January 13,
2014, in San Francisco at 2:30 PM (Pacific).
Interested parties may listen via live audio broadcast to the presentation
over the internet at http://investor.sigmaaldrich.com/. Users can click the
"Webcast" icon to access this file.
Interested parties may also view the presentation slides on the Company's
investor relations website – http://investor.sigmaaldrich.com/. The slides
(titled "Investor Presentation") will be available on the website at or before
the time of the Company's presentation at the conference.
About Sigma-Aldrich: Sigma-Aldrich, a leading Life Science and High
Technology company focused on enhancing human health and safety, manufactures
and distributes more than 200,000 chemicals, biochemicals and other essential
products to more than 1.4 million customers globally in research and applied
labs as well as in industrial and commercial markets. With three distinct
business units – Research, Applied and SAFC Commercial – Sigma-Aldrich is
committed to enabling science to improve the quality of life. The Company
operates in 38 countries, has more than 9,000 employees worldwide and had
sales of $2.6 billion in 2012. For more information about Sigma-Aldrich,
please visit its website at www.sigma-aldrich.com.
SOURCE Sigma-Aldrich Corporation
Contact: Debi Fakes, Investor Relations, Sigma-Aldrich Corporation,
Press spacebar to pause and continue. Press esc to stop.